COMMUNIQUÉS West-GlobeNewswire

Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2017

22/02/2018 - 22:01

EMERYVILLE, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today reported recent achievements and financial results for the fourth quarter and full-year ended December 31, 2017. “ [...]

Tabula Rasa HealthCare CEO Presents at IBC Innovation Day

22/02/2018 - 20:43

MOORESTOWN, NJ, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (“TRHC”) (NASDAQ: TRHC ) Chairman and CEO Calvin H. Knowlton, PhD, spoke at Independence Blue Cross (IBC) Innovation Day 2018 at the [...]

New Published Study Reports Cardiosphere-Derived Cells Improved Skeletal and Cardiac Muscle Function in Mouse Model of Duchenne Muscular Dystrophy

22/02/2018 - 19:23

LOS ANGELES, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced the online publication in Stem Cell Reports of a new study by researchers at the Smidt Heart Institute at Cedars-Sinai [...]

Interpace Diagnostics’ CEO Interviewed on The RedChip Money Report

22/02/2018 - 19:00

PARSIPPANY, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]

Core Mobility Solutions Launches the LifeGlider Personal Mobility Device

22/02/2018 - 18:30

SAN JOSE, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Core Mobility Solutions, a new mobility device manufacturer, today announced the first commercial launch of the LifeGlider™ at the American Physical Therapy [...]

Tetra Bio-Pharma Announces the Completion of GrowPros Transaction

22/02/2018 - 18:11

OTTAWA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Company ”) (TSX-V: TBP ) (OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce the [...]

Analogic to Demonstrate its Airport Checkpoint CT Scanner, ConneCT, in Four Global Regions by July 2018

22/02/2018 - 17:30

PEABODY, Mass., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ), enabling the world’s medical imaging and aviation security technology, today announced that the company intends to demonstrate the [...]

ELSALYS BIOTECH concludes with THEA a license option agreement on its ELB011 program in ophthalmology

22/02/2018 - 17:01

ELSALYS BIOTECH concludes with THEA a license option agreement on its ELB011 program in ophthalmology ELB011, a first-in-class antibody program, demonstrates an anti-angiogenic effect on the formation of new blood [...]

ELSALYS BIOTECH conclut avec THEA une option de licence sur son programme ELB011 en ophtalmologie

22/02/2018 - 17:01

ELSALYS BIOTECH conclut avec THEA une option de licence sur son programme ELB011 en ophtalmologie ELB011 est un programme d'anticorps first-in-class ayant démontré un effet anti-angiogénique sur la formation de néo- [...]

Tempus Launches Tempus xE, Whole Exome Sequencing to Empower Data-Driven Cancer Care and Research

22/02/2018 - 16:30

CHICAGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, has launched a new [...]

Sienna Senior Living Inc. Announces Closing of Over-Allotment Option

22/02/2018 - 15:41

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) [...]

Vistin Pharma ASA : Invitation to presentation of Q4 2017 results

22/02/2018 - 15:38

Oslo, 22 February 2018 Vistin Pharma ASA (OSE: VISTIN) will release its fourth quarter 2017 results on Tuesday 27 February 2018. The results will be presented by Vistin Pharma's CEO Kjell-Erik Nordby and CFO Gunnar [...]

Merit Medical to Participate at Six Conferences

22/02/2018 - 15:29

BTIG – March 1 Raymond James – March 7 Barclays – March 15 Oppenheimer – March 21 Needham – March 28 Sidoti – March 29 SOUTH JORDAN, Utah, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI ), a [...]

Midland, TX Hand Surgeon Launches Custom Specialty Website with Responsive Design

22/02/2018 - 15:01

MIDLAND, Texas, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Injuries and conditions of the hand and wrist often require the advanced skill of a plastic surgeon who has undergone extensive education in the delicate art of hand [...]

Mount Tam Biotechnologies Announces that the European Patent Office Has Allowed a Key Patent for Lead Compound TAM-01

22/02/2018 - 15:00

NOVATO, CA , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to announce the [...]

Radient Technologies Inc. Named to the 2018 TSX Venture 50 List of Companies

22/02/2018 - 15:00

EDMONTON, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX-V: RTI ), a world leader in industrial-scale natural ingredient extraction, purification and formulation [...]

Tower One to Spin Out USA-Based TCTS

22/02/2018 - 15:00

VANCOUVER, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (the “Company ” or “ Tower One ”) is pleased to announce that it intends to spin-out its [...]

Tetra Bio-Pharma Announces Filing of Restated Financial Statements and MD&A

22/02/2018 - 14:59

OTTAWA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Corporation ”) (TSX-V: TBP ) (OTCQB:TBPMF), announced today it has filed restated Condensed Consolidated interim financial statements ( [...]

Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017

22/02/2018 - 14:45

LONDON, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]